AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune's Anti-TDP-43 Antibodies into Clinical DevelopmentGlobeNewsWire • 11/09/20
AC Immune's Alzheimer's Setback, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 10/30/20
Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic AgentGlobeNewsWire • 10/09/20
AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s DiseaseGlobeNewsWire • 09/23/20
AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/11/20
Do Options Traders Know Something About AC Immune (ACIU) Stock We Don't?Zacks Investment Research • 09/01/20
All You Need to Know About AC Immune (ACIU) Rating Upgrade to Strong BuyZacks Investment Research • 08/06/20
AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat NeurodegenerationGlobeNewsWire • 08/03/20
AC Immune Wins Prestigious Award to Develop a “Game-Changing” Parkinson’s Diagnostic ToolGlobeNewsWire • 07/30/20
AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic AgentGlobeNewsWire • 07/28/20
AC Immune to Present Advances in Two of the Company’s World Leading Programs at the Upcoming Alzheimer’s Association International ConferenceGlobeNewsWire • 07/23/20
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear PalsyGlobeNewsWire • 07/07/20